Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genomic Solutions was a prominent developer and manufacturer of automated systems and consumables for genomic and proteomic research. The company's portfolio featured high-throughput DNA microarray systems, robotic protein purification platforms, and advanced software for bio-image analysis. These tools were essential for pharmaceutical and academic researchers seeking to automate the complex workflows of functional genomics and drug target identification. Founded in 1997 and headquartered in Ann Arbor, Michigan, the company played a pivotal role in the early automation of 'omics' workflows. Following its acquisition by Harvard Bioscience in 2002, its operations were integrated into the parent company's laboratory equipment division. The company's legacy remains in the foundational automation technologies used in modern molecular biology laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genomic Solutions.